TAM
VRTX icon

Trust Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Trust Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Sell
2,827
-29
-1% -$12.9K 0.09% 74
2026
Q1 		$1.28M Hold
2,856
– – 0.09% 72
2025
Q4 		$1.29M Sell
2,856
-106
-4% -$45.7K 0.09% 77
2025
Q3 		$1.16M Hold
2,962
– – 0.08% 81
2025
Q2 		$1.32M Hold
2,962
– – 0.1% 76
2025
Q1 		$1.44M Buy
2,962
+22
+0.7% +$10.3K 0.12% 67
2024
Q4 		$1.18M Hold
2,940
– – 0.09% 79
2024
Q3 		$1.37M Hold
2,940
– – 0.11% 67
2024
Q2 		$1.38M Hold
2,940
– – 0.12% 65
2024
Q1 		$1.23M Hold
2,940
– – 0.11% 73
2023
Q4 		$1.2M Hold
2,940
– – 0.12% 69
2023
Q3 		$1.02M Hold
2,940
– – 0.11% 72
2023
Q2 		$1.03M Hold
2,940
– – 0.11% 73
2023
Q1 		$926K Buy
2,940
+54
+2% +$16.2K 0.1% 78
2022
Q4 		$833K Hold
2,886
– – 0.1% 80
2022
Q3 		$836K Buy
2,886
+211
+8% +$60.7K 0.11% 73
2022
Q2 		$754K Buy
2,675
+119
+5% +$31.9K 0.11% 77
2022
Q1 		$667K Buy
2,556
+60
+2% +$14.2K 0.08% 95
2021
Q4 		$548K Hold
2,496
– – 0.07% 108
2021
Q3 		$453K Buy
2,496
+167
+7% +$32.6K 0.06% 122
2021
Q2 		$470K Buy
2,329
+240
+11% +$50.2K 0.06% 112
2021
Q1 		$449K Buy
2,089
+372
+22% +$81.7K 0.06% 109
2020
Q4 		$406K Buy
1,717
+410
+31% +$94.1K 0.06% 100
2020
Q3 		$356K Buy
1,307
+589
+82% +$162K 0.06% 74
2020
Q2 		$208K Buy
+718
New +$195K 0.04% 71

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Trust Asset Management's VRTX Position: Q2 2026 in Review

Trust Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 1% in Q2 2026, selling an estimated $12.9K and leaving 2,827 shares worth $1.4M. The position accounts for 0.09% of the portfolio, ranked #74.

Trust Asset Management first reported a position in VRTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.44M in Q1 2025. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Trust Asset Management held 2,827 shares of Vertex Pharmaceuticals worth $1.4M as of Q2 2026.
  • Trust Asset Management sold 29 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
  • Vertex Pharmaceuticals made up 0.09% of Trust Asset Management's portfolio in Q2 2026, its #74 holding.
  • Trust Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • Trust Asset Management's Vertex Pharmaceuticals position peaked at $1.44M in Q1 2025.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Trust Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.